Scientists are launching a new global study to see whether cannabidiol (CBD) can treat people with psychosis or psychotic symptoms.CBD is currently only perscribed on the NHS for children and adults with rare, severe epilepsy and adults with vomiting or nausea caused by chemotherapy.Oxford University's department of psychiatry has been awarded 16.5m by charitable foundation Wellcome to launch a clinical trial later this year.
[
add
]
[
|
|
...
]